Our previous research has confirmed that G6PD activity is abnormally elevated in ccRCC (16, 19), suggesting that its upstream regulator, BANCR, may play a pivotal role in glucose metabolism reprogramming. This evidence concerns the gene G6PD and nonpapillary renal cell carcinoma.